We advise re patent issues, extension of supplementary protection certificates, regulatory issues, acquisitions of local pharmaceutical companies, pharmaceutical distributors, distribution and license agreements, clinical trials, start-up, and market entry issues.

We advised:

• the leading European producer of generic drugs re acquisitions of a local pharmaceutical producer, of a pharmaceutical distribution company, distribution, regulatory, license agreements, patent issues, supplementary protection certificates;

• a German clinical research organization re healthcare regulations, and clinical trials matters;

• an European generic drugs company re market entry, start-up operations, competition, distribution, and regulatory issues;

• a US multinational biopharmaceutical company re pharmaceuticals distribution, healthcare regulatory issues, and clinical trials matters;

• the leading Dutch healthcare technology company re the sale of medical equipment for a new hospital;

• a French multinational pharmaceutical company re patent issues;

• a German pharmaceutical company re patent issues;

• a leading German pharmaceutical company re marketing, regulatory issues;

• a US global clinical research organization re clinical trials matters;

• a Dutch clinical research organization re healthcare regulatory issues, and clinical trials matters;

• a US pharmaceutical company re market entry, start-up operations, pharmaceutical distribution, regulatory issues.